Leishmania (Leishmania) amazonensis-induced cutaneous leishmaniasis in the primate Cebus apella: a model for vaccine trials.
about
A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous LeishmaniasisWild and synanthropic reservoirs of Leishmania species in the AmericasIdentification of differentially expressed proteins from Leishmania amazonensis associated with the loss of virulence of the parasitesAn 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis.Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection.Small Myristoylated Protein-3, Identified as a Potential Virulence Factor in Leishmania amazonensis, Proves to be a Protective Antigen against Visceral Leishmaniasis.
P2860
Leishmania (Leishmania) amazonensis-induced cutaneous leishmaniasis in the primate Cebus apella: a model for vaccine trials.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Leishmania (Leishmania) amazon ...... a: a model for vaccine trials.
@en
type
label
Leishmania (Leishmania) amazon ...... a: a model for vaccine trials.
@en
prefLabel
Leishmania (Leishmania) amazon ...... a: a model for vaccine trials.
@en
P2093
P1476
Leishmania (Leishmania) amazon ...... a: a model for vaccine trials.
@en
P2093
José Augusto P C Muniz
Lourdes M Garcez
Maria do Carmo Brigido
Patrick A F Gomes
Patrícia K Ramos
Paula M De Luca
Railson A Souza
Sergio C Mendonça
P304
P356
10.1016/S0020-7519(02)00138-8
P577
2002-12-01T00:00:00Z